DrugCard ran a live webinar titled What the Demo Doesn't Show: Lessons from Selecting and Implementing Computerised Systems in Pharmacovigilance with Jan Kolouch, covering vendor selection, data migration, and integrations.
Public source
Publisher name
Public post
That's a wrap! 🎉 Yesterday we ran "What the Demo Doesn't Show: Lessons from Selecting and Implementing Computerised Systems in Pharmacovigilance" with Jan Kolouch - and…
Company
DrugCard
AI-powered pharmacovigilance automation platform for global and local literature monitoring and regulatory intelligence.
- Industry
- Pharmaceutical Manufacturing
- Location
- Tallinn, EE
- Company size
- 11–50 employees
About DrugCard
DrugCard provides a cost-effective and regulatory compliant platform that automates pharmacovigilance — from global and local literature monitoring to regulatory tracking and case management. We help PV teams save time, stay compliant, and never miss a signal. Powered by AI, DrugCard transforms complex data into actionable insights, automates reporting and literature screening, and allows experts to focus on what matters most — strategic decisions and patient safety. Automated Local and Global Literature Monitoring Monitor both global databases like PubMed and local journals in one place. We already cover 151+ countries and 2300+ local journals, and counting. We add any journal you need — fast and without bureaucracy. No missed publications. No manual searches. Just faster, safer pharmacovigilance. AI-Powered Regulatory Intelligence Receive updates from global and local authorities in one centralized view — no more checking dozens of websites manually. DrugCard keeps your team informed on every regulatory change so you can act fast, stay compliant, and focus on what’s next — not on chasing updates. Adverse Event Database & Software Manage safety cases with an interface that feels intuitive, not overwhelming. Get the full “enterprise” functionality without the complexity, cost, or six months of training. Everything you need to collect, assess, and track adverse events efficiently — all in one secure, audit-ready platform. SimpleSearch — Free Tool for Drug Safety Searches It lets you explore global literature instantly, no setup or subscription required. It’s fast, accurate, and built for PV professionals who need reliable results — right now. Pharmacovigilance Services Extend your in-house capabilities with our PV specialists. DrugCard combines automation with human expertise — from literature review and reporting to quality checks and documentation. You get precision, consistency, and compliance delivered by experts who understand your needs.
See moreLatest activity
Latest activity from DrugCard
7 signals
Technology & Infrastructure
DrugCard's web crawler DrugCardBot has been officially verified by Cloudflare and listed in their public Bots Directory as a Verified bot.
Presence & Recognition
DrugCard is attending the World Patient Safety Congress Europe 2026 in Amsterdam at Booth 507 from 22 to 24 September 2026.
Presence & Recognition
DrugCard released the recording of a webinar featuring Dmytro Horilyk and Jan Kolouch following a demo.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Allucent
Allucent is hosting a webinar with Nextrove pharmacovigilance experts on AI-enabled pharmacovigilance and practical approaches to AI in adverse event reporting and case processing.
Presence & Recognition
Polish Society of Pharmacovigilance (Polskie Towarzystwo Bezpiecznej Farmakoterapii, PTBFarm)
Polish Society of Pharmacovigilance (Polskie Towarzystwo Bezpiecznej Farmakoterapii, PTBFarm) hosted a webinar titled Otyłość – zrozumieć, leczyć, wspierać. Bezpieczna droga do zdrowia
Presence & Recognition
Kintiga
Kintiga hosted an online webinar titled Leveraging AI in Evidence Generation and Market Access on 14 October 2026, featuring industry experts Dr. Lydia Frick and Dr. Daniel Brand.
Presence & Recognition
DIA
DIA hosted a free QPPV Talks webinar on September 3, 2026, featuring Benjamin Keserue and Karin Kempe discussing the different faces of the QPPV role across consultancy, big pharma, and smaller companies.
Presence & Recognition
Cytel